MeSH term
Frequency | Condition_Probility | Biopsy | 2 | 0.0 |
Humans | 33 | 0.0 |
Adolescent | 7 | 0.0 |
Adult | 14 | 0.0 |
Aged | 5 | 0.0 |
Child | 8 | 0.0 |
Child, Preschool | 4 | 0.0 |
Comparative Study | 4 | 0.0 |
Female | 18 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
Genes, Dominant/*genetics | 2 | 2.0 |
Lamin Type A | 11 | 50.0 |
Lamins | 15 | 28.0 |
Male | 16 | 0.0 |
Middle Aged | 12 | 0.0 |
Mutation/genetics | 3 | 0.0 |
Nuclear Proteins/*genetics | 11 | 2.0 |
Pedigree | 9 | 0.0 |
Phenotype | 10 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Prevalence | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 20 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Animals | 10 | 0.0 |
Base Sequence | 3 | 0.0 |
Consanguinity | 2 | 0.0 |
Mice | 8 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Muscular Dystrophies/*genetics | 3 | 3.0 |
Muscular Dystrophy, Emery-Dreifuss | 2 | 40.0 |
Mutation/*genetics | 4 | 0.0 |
Alleles | 5 | 0.0 |
Body Mass Index | 3 | 0.0 |
Gene Frequency | 3 | 0.0 |
Genotype | 8 | 0.0 |
Laminin/*genetics | 2 | 4.0 |
Leptin/blood | 2 | 3.0 |
*Variation (Genetics) | 2 | 0.0 |
Lipodystrophy/*genetics | 3 | 75.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
English Abstract | 4 | 0.0 |
*Mutation, Missense | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Exons | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
*Mutation | 6 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
Myocardium/pathology | 2 | 2.0 |
Amino Acid Substitution | 2 | 0.0 |
*Point Mutation | 2 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Lamins/*genetics | 3 | 75.0 |
Skin/pathology | 2 | 0.0 |
Fibroblasts | 2 | 0.0 |
Lamin Type A/*genetics | 5 | 100.0 |
Cell Line | 2 | 0.0 |
Survival Rate | 2 | 0.0 |
Aging/genetics | 2 | 5.0 |
Japan/epidemiology | 2 | 0.0 |
